首页 >
法规速递
-
Regulatory and procedural guideline: Guidance document on voting in the framework of discussion and adoption of CHMP opinions-2023/7/26
2023-07-28查看详情 > -
国家药监局关于修订裸花紫珠制剂说明书的公告（2024年第17号）-2024/2/23
2024-03-12查看详情 > -
Page: Clinical trials in human medicines-2025/1/31
2025-02-05查看详情 > -
Document: Agenda of the PRAC meeting 10-13 March 2025-2025/3/10
2025-03-11查看详情 > -
Document: Superseded - Rules of procedure of the Emergency Task Force (ETF)-2025/4/11
2025-04-13查看详情 > -
Document: Timetable: Type II variation and worksharing application assessment - ATMP-2025/5/23
2025-05-26查看详情 > -
Document: Process for submitting existing data on medicinal products authorised for human use – SIAMED II & XEVMPD to PMS deltas - Chapter 9-2025/6/30
2025-07-01查看详情 > -
国家药监局关于发布《医疗器械生产许可与备案管理基本数据集》等2个信息化标准的公告 （2025年第75号） -2025/8/1
2025-08-01查看详情 > -
关于公开征求《药物研发与技术审评沟通交流管理办法（2025年版）》意见的通知-2025/9/19
2025-09-22查看详情 > -
Document: Minutes of the PRAC meeting 1-4 September 2025-2025/10/24
2025-10-27查看详情 >
